Aaron Hoppe UCD Portfolio
36
02
BUSINESS CONTEXT Currently there are no systems which deliver such a service. In the UK 5.4 million people are receiving treatment for asthma, related expenditure is approximately 1 billion a year. The asthma telemedicine system can help the NHS achieve organisational objectives: Enhanced sharing of health-related data, to better the reliability of clinical judgments. Imparting advice to patients in a timely and cost-effective manner. Reduced hospital admissions without a resulting increase in mortality rates, an efficient resource saving measure. Provide better healthcare to those unable to regularly access services. E.g. Users in isolated locations The UK has among the highest prevalence rates of asthma symptoms in children worldwide; highlighting the importance of this services introduction.
MATRIX CHECKLIST This list of values in rows and columns allows me to systematically identify, analyse, and rate the performance of relationships between sets of values and information needed in the system. Elements of this matrix show decisions based on certain decision criteria. 03
STAKEHOLDER DIAGRAM The main users of the system shall be the asthma patient in lieu of a clinical visit. Their nature of use involves monitoring symptoms and submitting peak flow test readings, it’s likely they will have the system installed at home. In some cases, very young, old or disabled patients, will require their care giver to operate the telemedicine system. The other primary user shall be medical professionals, who will analyse the user’s data on the system, providing personalised feedback. They will do so remotely at the facility they work at.